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2Abstract
Alterations in the circadian blood pressure pattern are frequently observed in hypertension 
and lead to increased cardiovascular morbidity. However, there are no studies that have 
investigated a possible implication of the Period2 gene, a key component of the molecular 
circadian clock, on the circadian rhythms of blood pressure and heart rate. To address this 
question, we monitored blood pressure, heart rate and locomotor activity 24h a day by 
telemetry in mice carrying a mutation in the Period2 gene and in wild type control mice.  
Under a standard 12h/12h light-dark cycle mutant mice showed a mild cardiovascular 
phenotype with an elevated 24h heart rate, a decreased 24h diastolic blood pressure and an 
attenuation of the dark-light difference in blood pressure and heart rate.  Locomotor activity 
was similar in both groups and did not appear to explain the observed hemodynamic 
differences.  When mice were placed under constant darkness during 8 consecutive days, wild 
type mice maintained 24h rhythms whereas there was an apparent progressive loss of 24h 
rhythm of blood pressure, heart rate and locomotor activity in mutant mice.  However, a chi-
square periodogram revealed that circadian rhythms were preserved under complete absence 
of any light cue, but with shorter periods by about 40 min, leading to a cumulative phase shift 
towards earlier times of about 5h and 20 min by the end of the 8th day.  When heart rate, mean 
arterial pressure and activity were recalculated according to the endogenous circadian periods 
of each individual mouse, the amplitudes of the circadian rhythms (“subjective night”-
“subjective day” differences) were maintained for all variables studied.   Our data show that 
mutation of the Period2 gene results in an attenuated dipping of blood pressure and heart rate 
during both light-dark cycles and constant darkness, and in shorter circadian periods during 
constant darkness.  
Key words: circadian rhythm, clock genes, heart rate, blood pressure, telemetry 
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Introduction
 Circulatory demands change greatly over the day and night, and the ability to 
anticipate these changes is beneficial to the survival of the individual. Blood pressure (BP), 
heart rate (HR), cardiac output and stroke volume change rhythmically according to a 24-hour 
cycle, in humans being higher during the day than during the night (20; 23). A number of 
studies provide evidence that the endogenous circadian oscillating system in the 
suprachiasmatic nucleus (SCN) plays an important role in cardiovascular control as SCN 
lesion eliminates 24-h rhythm of BP and HR in experimental animals (15; 36; 37). 
 Perturbations of circadian rhythms may contribute to cardiovascular pathology. 
Disturbances at the level of central circadian clock are suggested in human hypertension (12; 
13) as well as in some animal models of hypertension (9; 10).  Hypertensive patients whose 
average night-time BP fails to ‘dip’ relative to their average day-time BP by at least 10% 
(‘non-dippers’) have a significantly greater frequency of left ventricular hypertrophy, 
microalbuminuria, and stroke (14; 29; 41) than do individuals whose BP drops during the 
night by 10% or more. 
 In mammals, circadian rhythms of physiology, biochemistry and behavior are 
orchestrated by a master clock situated in the SCN of the hypothalamus (49).  The 
endogenously generated circadian rhythm maintains a period of approximately 24 hours even 
in the absence of environmental cues (33). Molecular circadian regulation engages a 
transcription–translation feedback loop comprising clock proteins, CLOCK, BMAL1, PER(s) 
and CRY(s) (4; 8; 40).  Circadian expression of clock genes has also been demonstrated 
throughout the body, such as in the heart (38), liver (19), adrenal cortex (6), or kidney and 
other organs (5). 
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4 The Period 2 (Per2) gene is a key molecular component in controlling mammalian 
circadian rhythms (2) at the levels of gene expression, physiology and pathology. A robust 
circadian fluctuation of Per2 mRNA expression was discovered not only in the SCN but also 
in many peripheral tissues. The Per genes are crucial for circadian phase shifts by delaying 
the clock phase and regulates expression of another clock gene (Bmal1) in a positive manner. 
Furthermore, alterations in Per2 genes affect many biochemical processes, showing the 
multiple facets of the Per2 gene (reviewed by (3)).  The behavioral phenotype of Per2
mutants in constant darkness is characterized by short period rhythms and a progressive loss 
of the circadian rhythm of wheel-running locomotor activity (51).  In addition, a lack of food 
anticipation (seen through the lack of food-anticipatory activity and lack of body temperature 
changes in anticipation of food) is specifically associated with a mutation of Per2,
demonstrating the critical involvement of this gene in the anticipation of meal time (11).  
Several authors have already suggested potential involvement of Per2 gene in regulation of 
cardiovascular system. It was shown that the protein encoded by Per2 gene (PER2) is 
expressed in circadian manner in aortic smooth muscle cells (32) and that disturbed diurnal 
rhythm alters Per2 gene expression both in SCN and the heart of a mouse model of pressure 
overload cardiac hypertrophy (22).  In addition, Per2 mutant mice display altered vascular 
endothelial function (48). However, there are no studies that have directly analyzed the role of 
the Per2 gene on the circadian control of BP and HR.  To address this question, we analyzed 
in Per2 mutant mice and wild type control mice the circadian rhythms of BP, HR and 
locomotor activity, both in the presence and in the absence of the most powerful external cue, 
i.e. the light-dark (LD) cycle. 
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Methods
Animals 
 Mutant mice (mPer2Brdm1), designated here as Per2 mutants, were obtained from 
Zheng et al. (51) and propagated in our own facility.  In Per2 mutants PER2 protein is lacking 
the carboxy-terminal half of the PAS B and the entire PAC domain, resulting in a 
significantly shortened protein that lacks possible dimerisation sites (reviewed by (3)).  All 
experiments were performed on adult 3-4 months old wild-type (WT) (129 SvEvBrd X 
C57B16-Ty) and Per2 mutant mice. In this study we used only male mice to avoid estrous-
related variations in circadian pattern of BP, HR and locomotor activity, which have been 
described in female rats (43; 50) and mice (17).  Homozygous mutants as well as wild types 
were kept on an artificial 12h/12h LD cycle with lights off from 18.00 to 6.00 h. Temperature 
and humidity were kept stable at 22 ± 1oC and 55 ± 5%, respectively. Animals were housed 
individually and provided with normal chow (Diet 3433, Provimi-Kliba, Switzerland) and 
water ad libitum. The animal experimental protocol was approved by the Ethical Committee 
of State Veterinary Office of Fribourg, Switzerland. 
Blood pressure telemetry 
 All surgical procedures were performed using aseptic techniques, premedication with 
atropine sulphate 0.03 mg/kg + carprofen 10 mg/kg i.m. and under general anesthesia with 
ketamine 90 mg/kg + xylazine 10 mg/kg i.p.  All mice were instrumented with an arterial 
catheter connected to an implantable transducer (model TA11PA-C10, Data Sciences 
International, St. Paul, MN, U.S.A.) to monitor arterial pressure and HR 24h a day by 
telemetry in unrestrained mice.  The tip of the telemeter catheter was inserted into the aortic 
arch via the left common carotid artery as described previously (46).  After completion of the 
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6procedure, the mice were housed in individual standard mouse cages (23 cm x 17 cm x 14 cm 
high, Indulab AG, Switzerland) for continuous BP and HR measurement and monitoring of 
daily food intake.  At least 12 days were given to animals to recover from surgery and for BP 
and HR to stabilize. 
 Animal cages were equipped with one RPC-1 plastic receiver (Data Sciences Int.) 
fixed on the bottom of the cage and connected to an analog output device (R11-CPA), 
allowing for the continuous recording of the analog pulsatile arterial pressure signal.  The 
signal was then fed to a 12-bit analog-to-digital converter, sampled at 1 kHz, and processed 
using customized algorithms for beat-to-beat analysis (24).  Locomotor activity was estimated 
from the number of counts provided by the receiver, reflecting movements of the animal 
above a certain threshold. Each telemeter transducer was calibrated before implantation, as 
well as after explantation. Corrections for offset drift were not needed because the drift was 
less than 2 mmHg in all mice. 
Experimental protocol 
 In all animals (27 Per2 mutants and 30 WT control mice) we studied basal HR, BP 
and locomotor activity under the standard 12h/12h LD cycle during two consecutive days 
(protocol 1).  In a subset of animals (9 Per2 mutants and 6 WT mice), we studied the effects 
of constant darkness (DD) on circadian periods of cardiovascular parameters (protocol 2).
After 2 days of control under 12h/12h LD cycle in a customized ventilated chamber, mice 
were submitted to 8 consecutive days of DD, with no exposure to external cues (noise or 
light) and with enough food and water to sustain the 8 days of DD.  This was followed by a 3-
day recovery under regular 12h/12h LD cycle. 
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Measurements under constant darkness  
Comparison of six methods for the determination of the period of circadian rhythm 
(Fourier analysis, autocorrelation, chi-square periodogram, linear regression of onset, 
interonset averaging and acrophase counting ) revealed that Fourier analysis and chi-square 
periodogram were superior to the other methods in the analysis of more complex waveforms 
(which more closely resemble actual circadian rhythms) (30).  Furthermore, when random 
noise was inserted into the original data set, the chi-square periodogram was more tolerant to 
low signal-to-noise ratio than Fourier analysis.  Thus, we used the chi-square periodogram 
(30; 31) to calculate circadian periods of mean arterial pressure (MAP), HR and activity for 
the 8 consecutive days under DD.  A resolution of 10 minutes (bin size) under DD was 
selected as input data, which give a 0.17h resolution of the computed periods.  
 First, the daily 24h-records for both LD and DD experimental days were divided in 
two equal periods of 12h, from 18.00-06.00 h (ZT12 to ZT24, representing “night”) and from 
06.00-18.00 h (ZT0 to ZT12, representing “day”) to compute daily mean “night” minus mean 
“day” differences, defined here as “night” – “day” difference. ZT stands for “Zeitgeber time”, 
i.e., time defined relative to experimental LD cycle where the onset of light defines the 
Zeitgeber time 0 (ZT0) and the onset of dark defines Zeitgeber time 12 (ZT12). Then, the 
circadian periods of HR, MAP and activity under DD, obtained by the chi-square 
periodogram, were used to calculate the “subjective” day/night cycle of each individual 
mouse and divided in two equal periods corresponding to “subjective day” (CT0 to CT12) and 
“subjective night” (CT12 to CT24) for these parameters. Again, we computed mean 
“subjective night” minus mean “subjective day” differences, defined here as “subjective 
night”- “subjective day” difference and plotted over CT, where CT stands for “Circadian 
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8time” i.e. standard of time based on the free-running period of a rhythm where the onset of 
activity defines circadian time 12 (CT12).  
A second analysis program (Cosinor periodogram by R. Refinetti, 
http://www.circadian.org/softwar.html) was used to compare the circadian periods between 
LD and DD.  This was necessary because the chi-square periodogram, although the most 
reliable tool when a sufficient number of input days is available, was not able to compute the 
period of circadian rhythms for two days of LD cycle. 
Finally, to compute the acrophase (time at which the peak of the rhythm is reached) 
and the threshold (time at which the trough of the rhythm is reached), we used a fitted cosine 
wave procedure (Acro program by R. Refinetti, http://www.circadian.org/softwar.html ) for 
both LD and each of the 8 days under DD. The times of acrophase and threshold are given in 
hours from midnight. 
Statistical analysis 
 All data are presented as mean ± standard error.  In protocol 1 an unpaired t-test was 
used to compare data between Per2 mutants and WT mice.  In protocol 2 daily changes from 
control baseline values were analyzed with an analysis of variance for repeated 
measurements, followed by a multiple comparisons Dunnett’s t test.  Comparisons between 
Per2 mutants and WT mice were done with an unpaired t-test, with Bonferroni correction in 
the case of multiple comparisons. All statistics were calculated using the GraphPad InStat 
statistical program, version 3.01.  A value of p < 0.05 was used for statistical significance. 
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Results
Basal hemodynamic values under 12h/12h LD cycle (protocol 1) 
 Basal values collected during two consecutive days of 12h/12h LD cycle (protocol 1) 
for MAP, systolic and diastolic pressures (SBP and DBP), HR and locomotor activity are 
given in Table 1.  Data are presented as 24h averages as well as separately for the light and 
the dark periods.  24-hour HR was higher in Per2 mutant mice than in WT mice.  BP tended 
to be lower in mutant mice, but this was significant only for DBP.  When analyzing separately 
light and dark periods, the increase in HR was confined to the light period whereas the 
decrease in DBP was significant only during the dark period.  Mean locomotor activity 
(expressed as number of activity signals received per 30 seconds) was similar in both types of 
mice. 
 In order to assess the influence of locomotor activity on hemodynamic parameters we 
reanalyzed the data by separating the 30-second periods in which the animal was moving 
(active periods) from the periods in which no apparent movements were detected (inactive 
periods), as shown in Table 2.  In fact, the higher HR in Per2 mutants seemed more related to 
the resting state as the difference in HR between WT and mutant mice was greater during 
periods of inactivity (see Table 2).  On the other hand, DBP tended to be lower in Per2 
mutants when the animals were active.  Although mean locomotor activity was similar in both 
types of mice (Table 1), Per2 mutants showed a slightly higher percentage of time spent 
active during the light period (Table 2).  
Differences between the 12h-dark period and the 12h-light period (dark-light 
difference) were computed and are reported in Figure 1.  Per2 mutants showed significant 
decreases in dark-light differences for MAP (panel A, p = 0.002) and HR (panel B, p = 
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0.0004), but not of locomotor activity (panel C). Dark-light differences were also significantly 
smaller for SBP and DBP (P = 0.01 and P < 0.0001, respectively; data not shown). 
Hemodynamic analysis under constant darkness (protocol 2) 
 Figure 2 illustrates the calculated circadian periods by chi-square periodogram in WT 
and Per2 mutant mice during constant darkness when all 8 consecutive days were pooled for a 
single analysis of the duration of the average circadian period.  In WT mice circadian periods 
were fully preserved and amounted to about 24h for MAP (23.94 ± 0.04 h), HR (24.00 ± 0.07 
h) and activity (24.05 ± 0.09 h).  Per2 mutants also showed rhythmicity under constant 
darkness, but with significantly shorter periods for MAP (23.31 ± 0.12 h), HR (23.26 ± 0.08 
h) and activity (23.33 ± 0.19 h) and a wider distribution of individual values. 
 The calculated circadian periods by cosinor periodogram in WT and Per2 mutant mice 
both during LD (pool of two consecutive days) and during DD (pool of 8 consecutive days) 
are shown in Table 3.  Under LD there were no differences in the circadian periods between 
WT mice and Per2 mutants for all three variables studied (MAP, HR and activity). During 
DD, however, Per2 mutants had significantly shorter circadian periods of MAP, HR and 
activity comparing to WT counterparts.  Comparing DD versus LD, WT mice showed similar 
circadian periods whereas Per2 mutants had shorter circadian periods (but significant only for 
MAP and HR).  
 Figure 3 (left panels A1, B1 and C1) shows the 12h/12h “night”-“day” difference for 
MAP, HR and locomotor activity during the two control days under 12h/12h LD cycle, during 
the 8 days of constant darkness (DD) and during the first 3 days of recovery under 12h/12h 
LD cycle. All data are plotted over ZT time, i.e. relative to experimental LD cycle.   During 
constant darkness, WT mice showed a preserved 12h/12h “night”-“day” difference for MAP, 
HR and locomotor activity during all 8 days of DD.  In contrast, Per2 mutant mice showed a 
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progressive alteration of the 12h/12h”night”-“day” difference for all 3 variables studied 
(panels A1, B1 and C1).  When the animals were returned under a normal 12h/12h LD cycle 
(3 days of recovery), WT mice maintained their stable “night”-“day” differences and Per2
mutant mice showed a progressive return of the “night”-“day” differences toward basal 
control values. 
 Because of the shorter circadian periods computed in Per2 mutants, “night”-“day” 
differences under DD were recalculated on the basis of the endogenous (i.e. free-running) 
circadian periods of MAP, HR and activity obtained for each individual mouse by the chi-
square periodogram, and are expressed as “subjective night” – “subjective day” difference.  
As shown in Figure 3 (right panels A2, B2 and C2), the time axis represents now, not a 24-
hour time based on 12h/12h LD cycle (ZT), but CT. Thus, the beginning of the “subjective 
day” is at CT0, and the beginning of the “subjective night” is at CT12.  Recalculated data 
showed that Per2 mutant mice were able to conserve circadian rhythms of all three variables 
under constant darkness.  As circadian periods in mutant mice under DD were significantly 
shorter than 24 hours, the mice were already in “subjective day” for about 5h and 20 min at 
the beginning of the light period upon return to normal 12h/12h LD after 8 days under DD.  
Thus, it was not possible to calculate the “night”-“day” difference according to the circadian 
periods during the 3 days of recovery.  The two control days under 12h/12h LD cycle are the 
same for all panels, as here CT = ZT. 
Figure 4 shows the acrophase and the threshold of the rhythms for MAP (panel A), 
HR (panel B) and activity (panel C). Data are plotted in hours from midnight during LD (as 
average for 2 control days) and for each of the 8 days under DD.  In WT mice both the 
acrophase and the threshold of the rhythms during all 8 days of DD remained similar to LD 
value. In contrast, Per2 mutants showed a progressive shift from LD that by the 8th day led to 
a cumulative advanced time shift of 4.9h for MAP threshold (from 14.2h to 9.3h) and 5.1h for 
ht
tp
://
do
c.
re
ro
.c
h
11
12
MAP acrophase (from 22.6h to 17.5h).  Similar results were found for HR threshold (5.4h 
advanced shift, from 12.5h to 7.1h) and HR acrophase (5.8h advanced shift, from 21.1h to 
15.3h), as well as for activity threshold  (5.8h advanced shift, from 13.4h to 7.6h) and activity 
acrophase (6h advanced shift, from 21.9h to 15.9h). 
Discussion 
 The present study focused on the possible role of the clock gene Per2 in the circadian 
control of BP and HR, as this gene is considered to be a key component of the molecular 
circadian clock (1; 16).  The most important findings of our study are that mutation of the 
Per2 gene results in an attenuation of the dark-light difference in BP and HR under LD cycle 
and shorter circadian periods of BP, HR and locomotor activity under constant darkness. 
 Under a standard LD cycle, Per2 mutant mice showed a cardiovascular phenotype 
characterized by a higher HR during the light period, a lower DBP during the dark period, and 
a decreased dark-light difference in BP and HR.  Since locomotor activity may represent a 
very important confounding factor in the analysis of BP and HR, particularly in mice (46; 47), 
we also compared hemodynamic values during periods of activity and inactivity, as shown in 
Table 2.  Intriguingly, the increase in HR during the light period and the decrease in DBP 
during the dark period were found during both active and inactive periods, suggesting that 
locomotor activity is not the major determinant of the phenotype difference between Per2
mutant and WT mice.  Furthermore, the average intensity of locomotor activity in Per2
mutants was not statistically different from that of WT mice under LD conditions (see Table 
1) despite a slightly greater percentage of time spent in active periods during the light period 
(see Table 2).  These data are consistent with previous observations that Per2 mutant animals 
do not differ in the amount of wheel running activity from their WT counterparts (27). 
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In addition, the Per2 mutant mice have a tendency for lower BP, which was significant 
only for DBP during the dark period. This was unexpected as we previously described that 
isolated vessels of Per2 mutant mice display altered vascular endothelial function due to a 
decreased production of nitric oxide and vasodilatory prostaglandins as well as an increased 
release of COX-1-derived vasoconstrictors (48). This could suggest that BP regulation is not 
dominated by peripheral clocks in blood vessels.  
Another interesting finding under LD cycle was an attenuation of the dark-light 
difference in Per2 mutants that was statistically significant for MAP and HR, but not for 
locomotor activity (Figure 1). We can only speculate on the causes of the attenuated dark-like 
difference. A possible explanation is an autonomic imbalance with an attenuation of 
sympathetic inhibition during the light period, consistent with the higher HR observed during 
this period. In fact, the autonomous nervous system is probably the most important 
mechanism by which the SCN controls the circadian rhythm of BP and HR (7; 38; 44). In 
humans, deregulation of the circadian control of the autonomic nervous system may lead to 
non-dipping pattern of blood pressure associated with and potential target-organ damage in 
hypertensive patients (29; 41) and, more recently published, in normotensive subjects (42).  
As shown in Table 3, a 24h-rhythm was preserved during LD in Per2 mutants and did 
not differ from WT mice. To assess free-running circadian rhythms in the absence of the most 
powerful external cue (Zeitgeber), i.e. the LD cycle, it is important to study animals under 
constant conditions. It is known that Per2 mutants under constant darkness have a shorter 
circadian rhythm period of wheel-running activity than their WT counterparts (51).  However, 
free-running circadian rhythm periods of BP and HR in Per2 mutants have not been reported. 
When both types of mice were placed under constant darkness during 8 consecutive days, WT 
mice conserved circadian rhythm amplitudes whereas there was an apparent progressive 
attenuation of BP, HR and locomotor activity rhythm amplitudes in mutant mice. However, 
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based on both chi-square and cosinor periodogram analyses, a circadian period for all 3 
variables studied (MAP, HR and locomotor activity) was observed in Per2 mutant mice, but 
was significantly shorter than in WT counterparts, as shown in Figure 2 and Table 3.  This 
shortening could be due to a defect in the central clock. Indeed, expression of Per2 in SCN of 
WT controls peaks at around ZT12 and in Per2 mutants at around ZT10 (51). This phase 
advance of Per2 expression in SCN could be responsible for the phase advance in daily 
rhythms observed in Per2 mutants.  Furthermore, patients with a mutation in the binding site 
for casein kinase 1 in the Per2 gene show a familial advanced sleep phase syndrome (45). A
daily shortening of circadian rhythms observed in our experiments would lead to a cumulative 
advanced phase shift of the “subjective” day/night cycle by the 8th day of DD, explaining the 
progressive attenuation in the circadian amplitudes seen in panels A1 to C1 of Figure 3 when 
data are plotted based on ZT.  When data were plotted using CT instead of ZT, Per2 mutants 
cannot be considered to be arrhythmic, at least not for the first 8 days under DD, based on the 
preservation of the amplitude of the circadian rhythms of MAP, HR and activity (panels A2 to 
C2 of Figure 3).  On the other hand, WT mice maintained a 24h rhythm even under the 
complete absence of any light cue. This finding is supported by the results seen in Figure 4, 
showing that the acrophase and the threshold of the rhythms in the WT mice under DD 
appeared at the same time of the day as in the LD period. In contrast, Per2 mutants showed a 
progressive advanced shift of the both acrophase and the threshold, leading to an average 
cumulative shift of between 5 to 6h by the end of the 8th day. This advanced shift in acrophase 
and threshold is consistent with the about 5h and 20 minutes phase advanced shift obtained 
with the chi-square periodogram. Moreover, the shortening of the rhythms seems to occur 
from the very first day of DD based on acrophase and threshold values in Figure 4. 
The shorter periods of BP and HR in Per2 mutants are probably not linked to the 
shorter period of activity.  First, a loss of the circadian rhythm of wheel-running activity in 
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Per2 mutants can occur very early (range between 2 and 18 days) upon introduction of DD 
(51). Second, two Per2 mutant mice in our study did not show a rhythm for locomotor 
activity with the chi-square periodogram, but had rhythms for MAP and HR during 8 days of 
DD.  This could imply that circadian locomotor activity rhythm is decoupled from MAP and 
HR rhythms in Per2 mutant mice, and probably the first one to be lost under constant 
conditions. The maintenance of HR circadian rhythms even when activity rhythms were lost 
is consistent with the finding in humans that the circadian rhythm in HR could be independent 
of the activity rhythm (18; 39). WT mice circadian period lengths under DD were very 
consistent for all animals. As shown in Figure 2, the highest value for MAP circadian period 
was 24.00h and the lowest value was 23.73h.  A similar narrow range was found for HR 
(highest value 24.33h, lowest value 23.83h) and for activity (highest value 24.5h, lowest value 
23.83h).  In contrast, Per2 mutant mice showed a wide distribution of the same parameters 
with MAP period ranging from 22.70h to 23.97h, HR period ranging from 23.00h to 23.62h, 
and locomotor activity period ranging from 22.50h to 24h00.  This lack of uniformity among 
period lengths in Per2 mutants further enhances the alteration of “night”-“day” differences 
under DD when a 12h/12h ZT cycle is used to calculate the data. 
 Substantial evidence has accumulated that the SCN orchestrates circadian oscillations 
in sympathetic and parasympathetic activity, and alterations in its function may thereby affect 
the cardiovascular system.  Deregulation of the circadian control of the endocrine system, 
mainly of the reactivity of the hypothalamic-pituitary-adrenal axis, may further impair the 
adaptation of the cardiovascular system to external challenges.  Moreover, alterations in the 
peripheral circadian clock mechanisms, particularly in the heart, kidney and vascular smooth 
muscle cells may compromise the harmonious regulation of cardiovascular function and 
jeopardize its ability to adapt to circadian changes in exogenous demands.  However, their 
quantitative contribution to the Per2 phenotype is not clear. 
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Perspectives 
 Epidemiological evidence shows that cardiovascular events occur more frequently at 
certain periods of the day in humans.  A number of cardiovascular pathologies such as 
myocardial ischemia (35), myocardial infarction (26), sudden cardiac death (25) and ischemic 
stroke (21), show a diurnal pattern.  Furthermore, circadian rhythm disruption is found 
commonly in patients with sleep apnea (28), transmeridian flight crews and shift workers 
(34), all of whom show higher than average prevalence of cardiovascular diseases.  A better 
understanding in the control of cardiovascular circadian rhythms may lead to health benefits.  
Our present results suggest that the Per2 gene provides a significant contribution to 
cardiovascular circadian rhythms. 
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Table 1. Summary of basal hemodynamic values and locomotor activity acquired 
during 12h/12h light-dark cycle in Per2 mutants and wild type control mice. 
Period Wild type  
(n =30) 
Per2 mutants 
 (n = 27) 
P value 
24h values HR (bpm) 520 ± 5 540 ± 5 0.007 
 SBP (mmHg) 128.7 ± 1.3 127.2 ± 5 ns 
 MAP (mmHg) 116.0 ± 1.1 113.8 ± 1.3 ns 
 DBP (mmHg) 104.3 ± 1.2 100.6 ± 1.4 0.05 
 Mean activity (a.u./30s) 2.0 ± 0.2 1.9 ± 0.1 ns 
Light period HR (bpm) 497 ± 5 529 ± 5 <0.0001 
 SBP (mmHg) 123.6 ± 1.2 123.3 ± 1.7 ns 
 MAP (mmHg) 110.9 ± 1.1 110.1 ± 1.4 ns 
 DBP (mmHg) 99.1 ± 1.2 97.1 ± 1.5 ns 
 Mean activity (a.u./30s) 0.9 ± 0.1 1.1 ± 0.1 ns 
Dark period HR (bpm) 539 ± 6 550 ± 5 ns 
 SBP (mmHg) 132.8 ± 1.3 130.5 ± 1.6 ns 
 MAP (mmHg) 120.2 ± 1.2 116.9 ± 1.3 ns 
 DBP (mmHg) 108.6 ± 1.3 103.5 ± 1.4 0.01 
 Mean activity (a.u./30s) 2.9 ± 0.3 2.6 ± 0.2 ns 
HR, heart rate; SBP, systolic blood pressure; MAP, mean arterial pressure; DBP, diastolic 
blood pressure; a.u., arbitrary units; ns, not significant. 
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Table 2. Summary of basal hemodynamic values during active and inactive periods 
under 12h/12h light-dark cycle in Per2 mutants and wild type control mice. 
Light period Inactive periods (%) 84.1 ± 1.0 80.1 ± 1.2 0.01 
 Active periods (%) 15.9 ± 1.0 19.9 ± 1.2 0.01 
 HR no activity (bpm) 486 ± 6 515 ± 6 0.001 
 HR activity (bpm) 561 ± 5 582 ± 4 0.002 
 SBP no activity (mmHg) 122.0 ± 1.3 121.0 ±1.7 ns 
 SBP activity (mmHg) 131.7 ± 1.6 132.9 ± 1.8 ns 
 MAP no activity (mmHg) 109.7 ± 1.1 108.6 ± 1.4 ns 
 MAP activity (mmHg) 117.7 ± 1.3 117.1 ± 1.5 ns 
 DBP no activity (mmHg) 98.0 ±1.3 95.6 ± 1.5 ns 
 DBP activity (mmHg) 105.1 ±1.3 103.1 ±1.6 ns 
Period Wild type  
(n =30) 
Per2 mutants 
(n = 27) 
P value 
24h values Inactive periods (%) 74.3 ± 1.1 72.2 ± 1.0 ns 
 Active periods (%) 25.7 ± 1.2 27.8 ±1 ns 
 HR no activity (bpm) 499 ± 5 521 ± 5 0.007 
 HR activity (bpm) 580 ± 5 587 ± 4 ns 
 SBP no activity (mmHg) 125.5 ± 1.3 124.0 ±1.7 ns 
 SBP activity (mmHg) 137.1 ± 1.5 135.6 ±1.7 ns 
 MAP no activity (mmHg) 113.3 ± 1.1 111.5 ± 1.3 ns 
 MAP activity (mmHg) 123.3 ± 1.2 120.4 ± 1.4 ns 
 DBP no activity (mmHg) 101.9 ±1.3 98.5 ± 1.4 ns 
 DBP activity (mmHg) 110.9 ± 1.4 106.1 ±1.5 0.02 
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Dark period Inactive periods (%) 65.2 ± 1.6 65.6 ± 1.2 ns 
 Active periods (%) 34.8 ± 1.6 34.4 ± 1.2 ns 
 HR no activity (bpm) 515 ± 6 528 ± 5 ns 
 HR activity (bpm) 587 ± 5 590 ± 5 ns 
 SBP no activity (mmHg) 129.3 ± 1.4 127.2 ±1.7 ns 
 SBP activity (mmHg) 139.0 ± 1.5 136.7 ±1.8 ns 
 MAP no activity (mmHg) 117.4 ± 1.2 114.6 ± 1.3 ns 
 MAP activity (mmHg) 125.5 ± 1.3 121.8 ± 1.5 ns 
 DBP no activity (mmHg) 106.2 ± 1.3 101.4 ±1.4 0.01 
 DBP activity (mmHg) 113.1 ± 1.4 107.4 ± 1.6 0.01 
HR, heart rate; MAP, mean arterial pressure; %, percentage; ns, not significant. 
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Table 3. Circadian rhythm periods as assessed by a Cosinor periodogram over 2 days of 
12h/12h light-dark cycle (LD) and over 8 days of constant darkness (DD) in 
Per2 mutants and wild type control mice 
WT mice Per2 mutants 
MAP (LD) 24.1 ± 0.4 h 24.5 ± 0.3 h  §§ 
MAP (DD) 24.2 ± 0.1 h 23.3 ± 0.1 h  *** 
HR (LD) 24.1 ± 0.3 h 24.6 ± 0.5 h  § 
HR (DD) 24.1 ± 0.04 h 23.2 ± 0.1 h  *** 
Activity (LD) 24.4 ± 0.5 h 24.6 ± 0.7 h 
Activity (DD) 24.0 ± 0.05 h 23.3 ± 0.2 h  *** 
HR, heart rate; MAP, mean arterial pressure. 
WT mice: n = 6; Per2 mutants: n = 9 (except n = 7 for locomotor activity under DD)  
LD vs. DD: §P < 0.05, §§P < 0.01 
Per2 mutant mice vs. WT mice: ***P < 0.001 
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Figure Legends 
Figure 1. Dark-light differences in mean arterial pressure (MAP, panel A), heart rate (HR, 
panel B) and locomotor activity (panel C) when plotted over 12h/12h light-dark cycles 
(n = 30 for wild type mice, n = 27 for Per2 mutant mice).  *** P < 0.001 (compared to 
wild type). Values for individual mice are plotted as separate symbols.  
Figure 2.  Circadian rhythm periods as assessed by a chi square periodogram over the 8 
consecutive days of constant darkness for mean arterial pressure (MAP, panel A), heart 
rate (HR, panel B) and locomotor activity (panel C).  (n = 6 for wild type mice, n = 9 for 
Per2 mutant mice except n=7 for locomotor activity).  In two Per2 mutant mice the 
periodogram for locomotor activity did not yield a period length due to arrhythmicity.) 
** P < 0.01; *** P < 0.001 (compared to wild type).  Values for individual mice are 
plotted as separate symbols. 
Figure 3. Left panels: “Night” - “day” differences in mean arterial pressure (MAP, panel 
A1), heart rate (HR, panel B1) and locomotor activity (panel C1) when plotted over 
12h/12h cycles (Zeitgeber time, ZT) before, during and after of 8 days of constant 
darkness (DD).  LD = light-dark cycle.  Right panels:  “Subjective night”-“subjective 
day” difference obtain from the same data based on recalculated individual circadian 
periods (Circadian time, CT).  (n = 6 for wild type mice, n = 9 for Per2 mutant mice 
except n = 7 for locomotor activity under constant darkness). * P < 0.05; § P < 0.001 
(compared to control LD baseline values) 
Figure 4. Acrophase and threshold of circadian rhythm for mean arterial pressure (MAP, 
panel A), heart rate (HR, panel B) and locomotor activity (panel C), for control light-
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dark cycle (LD) and for each individual of 8 days of constant darkness (DD). (n = 6 for 
wild type mice, n = 9 for Per2 mutant mice except n = 7 for locomotor activity under 
DD). § P < 0.05 compared to control LD baseline values;  
* P < 0.05 compared to wild type mice.  
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